机构:[1]State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China[2]Yunnan Key Laboratory of Primate Biomedical Research, Kunming, Yunnan 650500, China[3]Department of MRI, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650224, China医技片磁共振科云南省第一人民医院
This study was supported
by grants from the National Key Research and Development Program of
China (2018YFA0801400, 2018YFA0108503), by the National Natural
Science Foundation of China (31872973 and 32260197) and by the
Natural Science Foundation of Yunnan (202001BC070001,
CB22197S027A and 202101AT070278).
第一作者机构:[1]State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China[2]Yunnan Key Laboratory of Primate Biomedical Research, Kunming, Yunnan 650500, China[*1]State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China
推荐引用方式(GB/T 7714):
Gan Xue,Ren Jiahan,Huang Tianzhuang,et al.Pathological α-synuclein accumulation, CSF metabolites changes and brain microstructures in cynomolgus monkeys treated with 6-hydroxydopamine[J].NEUROTOXICOLOGY.2023,94:172-181.doi:10.1016/j.neuro.2022.12.001.
APA:
Gan Xue,Ren Jiahan,Huang Tianzhuang,Wu Kunhua,Li Shulin...&Wei Jingkuan.(2023).Pathological α-synuclein accumulation, CSF metabolites changes and brain microstructures in cynomolgus monkeys treated with 6-hydroxydopamine.NEUROTOXICOLOGY,94,
MLA:
Gan Xue,et al."Pathological α-synuclein accumulation, CSF metabolites changes and brain microstructures in cynomolgus monkeys treated with 6-hydroxydopamine".NEUROTOXICOLOGY 94.(2023):172-181